20 Best Dividend Healthcare Stocks Since January 2013

Today I'm screening for dividend stocks in the healthcare sector with the highest stock performance since the beginning of the year.

The 20 most successful companies have realized gained between 22.01 percent and 73.98 percent. The average capital gain was 36.24 percent. Despite the strong stock price hike, seventeen of them still have a buy or better rating.

Warner Chilcott (WCRX) has a market capitalization of $4.94 billion. The company employs 2,100 people, generates revenue of $2.541 billion and has a net income of $403.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $1.424 billion. The EBITDA margin is 56.04 percent (the operating margin is 19.48 percent and the net profit margin 15.86 percent).

Financial Analysis: The total debt represents 94.24 percent. Twelve trailing months earnings per share reached a value of $1.60. Last fiscal year, the company paid no dividends to shareholders. Forward P/E: 6.18.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 12.30, the P/S ratio is 1.95 and the P/B ratio is finally not calculable. The dividend yield amounts to 2.54 percent and the beta ratio has a value of 1.09.



Questcor Pharmaceuticals (QCOR) has a market capitalization of $2.74 billion. The company employs 557 people, generates revenue of $509.29 million and has a net income of $197.68 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $299.03 million. The EBITDA margin is 58.72 percent (the operating margin is 58.22 percent and the net profit margin 38.81 percent).

Financial Analysis: The total debt represents 0.00 percent of the company’s assets and the total debt in relation to the equity amounts to 0.00 percent. Due to the financial situation, a return on equity of 103.59 percent was realized. Twelve trailing months earnings per share reached a value of $3.23. Last fiscal year, the company paid $0.40 in the form of dividends to shareholders. Forward P/E: 9.65.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 14.26, the P/S ratio is 5.39 and the P/B ratio is finally 16.67. The dividend yield amounts to 2.17 percent and the beta ratio has a value of 0.67.



WellPoint (WLP) has a market capitalization of $24.52 billion. The company employs 43,500 people, generates revenue of $61.711 billion and has a net income of $2.655 billion. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $5.118 billion. The EBITDA margin is 8.29 percent (the operating margin is 6.26 percent and the net profit margin 4.30 percent).

Financial Analysis: The total debt represents 25.41 percent of the company’s assets and the total debt in relation to the equity amounts to 62.93 percent. Due to the financial situation, a return on equity of 11.28 percent was realized. Twelve trailing months earnings per share reached a value of $8.49. Last fiscal year, the company paid $1.15 in the form of dividends to shareholders. Forward P/E: 9.87.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 9.61, the P/S ratio is 0.40 and the P/B ratio is finally 1.05. The dividend yield amounts to 1.84 percent and the beta ratio has a value of 0.86.



Humana (HUM) has a market capitalization of $13.42 billion. The company employs 43,400 people, generates revenue of $39.126 billion and has a net income of $1.222 billion. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $2.354 billion. The EBITDA margin is 6.02 percent (the operating margin is 5.15 percent and the net profit margin 3.12 percent).

Financial Analysis: The total debt represents 14.69 percent of the company’s assets and the total debt in relation to the equity amounts to 33.18 percent. Due to the financial situation, a return on equity of 14.45 percent was realized. Twelve trailing months earnings per share reached a value of $8.93. Last fiscal year, the company paid $1.03 in the form of dividends to shareholders. Forward P/E: 9.97.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 9.54, the P/S ratio is 0.34 and the P/B ratio is finally 1.52. The dividend yield amounts to 1.27 percent and the beta ratio has a value of 1.04.



Take a closer look at the full list of the best performing healthcare dividend stocks with cheap price ratios. The average P/E ratio amounts to 26.33 and forward P/E ratio is 16.64. The dividend yield has a value of 4.07 percent. Price to book ratio is 2.98 and price to sales ratio 3.77. The operating margin amounts to 27.08 percent and the beta ratio is 0.40. Stocks from the list have an average debt to equity ratio of 1.26.

Here is the full table with some fundamentals (TTM):

Related stock ticker symbols:
QCOR, WCRX, UTMD, UHS, BMY, AET, CI, TMO, WLP, ENSG, WST, COO, STJ, BDX,
MDT, STE, JNJ, HUM, ALC, UNH

Disclosure: I am long BDX, MDT, JNJ. I receive no compensation to write about these specific stocks, sector or theme. I don't plan to increase or decrease positions or obligations within the next 72 hours.

For the other stocks: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I receive no compensation to write about any specific stock, sector or theme.